Site Members can sign up for company wide alerts
Lawsuit Overview
San Diego, Nov. 29, 2011 (Shareholders Foundation) -- An investor in NASDAQ:VRUS shares filed a lawsuit in State Court against directors of Pharmasset, Inc in effort to block the proposed acquisition of Pharmasset, Inc by Gilead Sciences, Inc for $137 per share. According to the complaint the plaintiff alleges that the defendants breached their fiduciary duties owed to Pharmasset, In...
You must register (for free) or login to view the entire case.